Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-19 Purchase | 2020-11-23 5:30 pm | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director | 197,716 | $15.12 | $2,989,466 | 2,827,883 (Indirect) | View |
| 2020-11-17 Purchase | 2020-11-19 8:15 pm | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director | 29,394 | $15.29 | $449,400 | 2,630,167 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-23 4:50 pm | Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 36,111 | $18 | $649,998 | 3,086,084 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-23 4:49 pm | Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner | 46,111 | $18 | $829,998 | 10,000 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-22 4:30 pm | Pandion Therapeutics Inc. | PAND | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 361,111 | $18 | $6,499,998 | 1,770,023 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-22 4:18 pm | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 361,111 | $18 | $6,499,998 | 2,262,301 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-21 7:51 pm | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 36,111 | $18 | $649,998 | 110,621 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-21 7:49 pm | Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner | 722,222 | $18 | $12,999,996 | 2,131,135 (Indirect Direct) | View |
| 2020-07-21 Purchase | 2020-07-21 7:47 pm | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 361,111 | $18 | $6,499,998 | 2,262,301 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-21 7:44 pm | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 50,111 | $18 | $901,998 | 545,090 (Indirect Direct) | View |
| 2020-07-21 Purchase | 2020-07-21 7:44 pm | Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner | 722,222 | $18 | $12,999,996 | 2,614,770 (Indirect Direct) | View |
| 2020-07-21 Purchase | 2020-07-21 7:39 pm | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner | 723,222 | $18 | $13,017,996 | 2,615,770 (Indirect Direct) | View |
| 2020-07-21 Purchase | 2020-07-21 7:39 pm | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 1,450 | $18 | $26,100 | 115,991 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-01 Equity Swap | 2021-04-01 7:59 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks | 504,454 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:58 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 87,764 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:57 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 3,621,894 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:55 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Freedman Edward D. Chief Operating Officer | 54,460 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:53 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | BELOFF GREGG See Remarks | 13,196 | $60 | 0 (Indirect) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:50 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 716,515 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner | 2,131,135 | $60 | 0 (Indirect) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director | 2,828,883 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:46 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer | 115,826 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:46 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director | 74,067 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:45 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Frail Donald Director | 61,113 | $60 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:43 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 5,674,221 | $60 | 0 (Indirect) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:37 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Larson Eric D Vice President, Finance | 22,125 | $60 | 0 (Direct) | View |
Ownership | 2021-03-04 06:06 am | N/A N/A | Pandion Therapeutics Inc. | PAND | Merck & Co. Inc. MERCK SHARP & DOHME CORP. 10% Owner | 0 | $0 | 0 (Indirect) | View |
| 2021-02-08 Option Award | 2021-02-10 4:47 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 221,367 | $0 | 221,367 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:46 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Freedman Edward D. Chief Operating Officer | 36,895 | $0 | 36,895 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:45 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks | 73,789 | $0 | 73,789 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:41 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 73,789 | $0 | 73,789 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:41 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Larson Eric D Vice President, Finance | 23,000 | $0 | 23,000 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:40 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer | 73,789 | $0 | 73,789 (Direct) | View |
| 2020-12-02 Option Award | 2020-12-04 8:04 pm | N/A 2030-12-01 | Pandion Therapeutics Inc. | PAND | Dorton Katina Director | 27,994 | $0 | 27,994 (Direct) | View |
Ownership | 2020-12-04 7:58 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Dorton Katina Director | 0 | $0 | 0 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-23 4:50 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 18,602,976 | $0 | 3,086,084 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-23 4:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner | 18,602,976 | $0 | 10,000 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-22 4:30 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 8,593,508 | $0 | 1,770,023 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-22 4:18 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 13,997 | $0 | 2,262,301 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-22 4:18 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 11,510,727 | $0 | 2,262,301 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 19,306,473 | $0 | 110,621 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:49 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner | 13,997 | $0 | 13,997 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner | 8,593,509 | $0 | 2,131,135 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:47 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 13,997 | $0 | 2,262,301 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:47 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 11,510,727 | $0 | 2,262,301 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:45 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | JDRF T1D Fund LLC 10% Owner | 2,506,728 | $0 | 426,333 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:44 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 13,997 | $0 | 545,090 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 19,435,374 | $0 | 545,090 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:44 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner | 13,997 | $0 | 2,614,770 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner | 8,593,509 | $0 | 2,614,770 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 21,530,967 | $0 | 3,754,051 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:39 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner | 13,997 | $0 | 2,615,770 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:39 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner | 11,458,013 | $0 | 2,615,770 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:39 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 28,227 | $0 | 115,991 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:39 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 42,966 | $0 | 115,991 (Direct) | View |